The Universal Journal of Emerging Infectious Diseases and Rare Diseases (UJEIRD) is published monthly. UJEIRD is a non profit, peer-reviewed, open access journal and publishes original articles in relevant areas including common infectious diseases including bacterial and viral emerging diseases, outbreaks, all communicable and non communicable diseases. Clinical and Laboratory-based research, together with reports of clinical trials, reviews, and some case reports dealing with the epidemiology, clinical diagnosis, treatment, and control of infectious diseases with particular emphasis placed on those diseases that are most common in under-resourced countries. The main agenda of this journal is to spread the innovative research carried out by the researchers and scientists across in the field of  microbiology, infectious diseases,  virology, bacteriology, mycology, vaccines and biomedical research across the World.  Besides, the Infectious Diseases, we are accepting articles relevant to Rare Diseases.  Rare disease in general affects a small percentage of the population. In some parts of the world, an orphan disease is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments. Orphan drugs are ones so created or sold.
 

Most of the rare diseases are genetically associated and thus are present throughout the person's entire life, even if symptoms do not immediately appear. Many rare diseases appear early in life, and about 30% of children with rare diseases will die before reaching their fifth birthday. With only three diagnosed patients in 27 years, ribose-5-phosphate isomerase deficiency is considered the rarest known genetic disease.
 

No single cut-off number has been agreed upon for which a disease is considered rare. A disease may be considered rare in one part of the world, or in a particular group of people, but still be common in another.

The US organisation Global Genes has estimated that more than 300 million people worldwide are living with one of the approximately 7,000 diseases they define as "rare" in the United States. 
 

The Editorial Board 

• Alpana Ray, University of Missouri, College of Veterinary Medicine, United States

• Zeng Xu, University of Florida, United States

• Alireza Heidari, California South University, United States

• Yarla, Novel Global Education Foundation, NSW, Australia.
  Member, American cancer association, United States

• Oner Ozdemir, Göztepe Teaching and Training Hospital, Turkey

• Sivakumar Joghi Thatha Gowder,  Ton Duc Thang University, Vietnam

• Viroj Wiwanitkit, Hainan Medical University, China

• Abdulghani Alsamarai, Tikrit University, Iraq

• Bhola Nath, AIIMS, India

• Naim Deniz Ayaz , Risk Assessment Commission of Contaminants, Turkey 

• Elena Germanovna Dmitrieva, Cand.biol.science’s for Clinical Pharmacology, Russia
  
  Our Associations & Collaborations

• Infinity Long Term Care Consulting 
  More Info: www.infinityltcare.com/services
  
  The Florida Poison Information Center Tampa (FPICT)
   
• NIHUB (Nursing Innovation Hub)
  More Info: www.innovatenursehub.com/who-we-are/
   
• Canadian Academy of Sciences of the Canadian Education Agency Inc.
  Ontario, Canada
   

• Opti-My-Wise-Life
  More Info: www.opti-my-wise-life.myshopify.com/password

• Medical Arrow
  More Info: www.medicalarrow.com

• Medvoyage Tourism & Education
  More Info: www.medicalarrow.com

• Medproinfo
  More Info: www.medproinfo.com

• Researchbib
  More Info: www.researchbib.com

• World Conference Alerts
  More Info: www.worldconferencealerts.com

• Course for Doctors
  More Info: www.coursefordoctors.com

• Medgate Today Magazine
  More Info: www.medgatetoday.com